Measurement of coagulation factors during rivaroxaban and apixaban treatment: Results from two crossover trials

Author(s):
Scheres, L.J.J.; Lijfering, W.M.; Middeldorp, S.; Cheung, Y.W.; Barco, S.; Cannegieter, S.C. (0000-0003-4707-2303); Coppens, M.
Published
2018
Publication type
Article / Letter to editor
apixabanblood coagulation testscoagulantsfactor Xa inhibitorsrisk assessmentrivaroxaban
Date issued
2018-10-31
Language
English
Is part of
Research and Practice in Thrombosis and Haemostasis (2018), Vol. 2, no. 4, p. 689-695
hdl
1887/86597
doi
10.1002/rth2.12142
URL
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6178718/pdf/RTH2-2-689.pdf